1. FRI0106 Preliminary results from a controlled trial (VISARA) to evaluate the humoural immune response to vaccines in RA patients treated with tocilizumab (TCZ). (23rd January 2014) Authors: Bingham, C.O.; Rizzo, W.; Klearman, M.; Hassanali, A.; Upmanyu, R.; Kivitz, A. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0132 Insulin resistance is improved by tocilizumab therapy in rheumatoid arthritis: results from the toward study. (23rd January 2014) Authors: Mirjafari, H.; Wang, J.; Klearman, M.; Harari, O.; Bruce, I. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0137 Risk factors for major adverse cardiovascular (CV) events (MACE) in rheumatoid arthritis (RA) patients treated with tocilizumab (TCZ). (23rd January 2014) Authors: Rao, V.U.; Pavlov, A.; Klearman, M.; Musselman, D.; Giles, J.T.; Bathon, J.M.; Sattar, N.; Lee, J.S. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0248 Baseline Data on Patients in Giacta (Tocilizumab in Giant Cell Arteritis). (9th June 2015) Authors: Tuckwell, K.; Collinson, N.; Klearman, M.; Dimonaco, S.; Stone, J.H. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 514 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0377 Classification Criteria for Giant Cell Arteritis: Data from Giacta Informing The Need for Revision. (15th July 2016) Authors: Tuckwell, K.; Collinson, N.; Klearman, M.; Dimonaco, S.; Stone, J.H. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0493 Pet/ct in patients with giant cell arteritis after 1 year of treatment with tocilizumab plus prednisone taper or only prednisone taper. (12th June 2018) Authors: Ishai, A.; Brouwer, E.; Maldini, C.; Stone, J.H.; Espigol-Frigole, G.F.; Cid, M.C.; Blockmans, D.; Carmellino, D.; Cimmino, M.; Muratore, F.; Slart, R.; Salvarani, C.; Narvaez Garcia, F.; De Vita, S.; Hellmich, B.; Dimonaco, S.; Klearman, M.; Petho-Schramm, A.; Tuckwell, K.; Collinson, N. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 774 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. LB0003 Tocilizumab (TCZ) monotherapy is superior to adalimumab (ADA) monotherapy in reducing disease activity in patients with rheumatoid arthritis (RA): 24-week data from the phase 4 adacta trial. (23rd January 2014) Authors: Gabay, C.; Emery, P.; van Vollenhoven, R.; Dikranian, A.; Alten, R.; Klearman, M.; Musselman, D.; Agarwal, S.; Green, J.; Kavanaugh, A. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OP0002 No difference in the risk of malignancy in tocilizumab versus tnf inhibitor initiators in patients with rheumatoid arthritis: a multi-database cohort study. (12th June 2018) Authors: Kim, S.C.; Pawar, A.; Desai, R.J.; Gale, S.; Klearman, M.; Sarsour, K.; Solomon, D.H.; Schneeweiss, S. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OP0165 Changes in Lipoprotein(A) after Treatment with Tocilizumab (TCZ), Adalimumab (ADA), and Methotrexate (MTX) in Patients with Rheumatoid Arthritis (RA). (10th June 2014) Authors: Gabay, C.; McInnes, I.; Kavanaugh, A.; Tuckwell, K.; Collinson, N.; Klearman, M.; Green, J.; Sattar, N. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OP0237 A comparison of pk and pd outcomes of tocilizumab in giant cell arteritis after sc and iv dosing. (12th June 2018) Authors: Mallalieu, N.L.; Stone, J.H.; Villiger, P.; Klearman, M.; Brockwell, L.; Dimonaco, S.; Charion, J.E. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗